Stryker Other Long-Term Assets 2010-2025 | SYK
Stryker other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Stryker other long-term assets for the quarter ending March 31, 2025 were $2.816B, a 2.44% increase year-over-year.
- Stryker other long-term assets for 2024 were $2.684B, a 0.41% increase from 2023.
- Stryker other long-term assets for 2023 were $2.673B, a 8.48% increase from 2022.
- Stryker other long-term assets for 2022 were $2.464B, a 8.88% increase from 2021.
| Stryker Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $2,684 |
| 2023 | $2,673 |
| 2022 | $2,464 |
| 2021 | $2,263 |
| 2020 | $2,009 |
| 2019 | $1,671 |
| 2018 | $801 |
| 2017 | $1,301 |
| 2016 | $1,141 |
| 2015 | $1,151 |
| 2014 | $1,293 |
| 2013 | $494 |
| 2012 | $544 |
| 2011 | $537 |
| 2010 | $151 |
| 2009 | $137 |
| Stryker Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $2,816 |
| 2024-12-31 | $2,684 |
| 2024-09-30 | $2,833 |
| 2024-06-30 | $2,790 |
| 2024-03-31 | $2,749 |
| 2023-12-31 | $2,673 |
| 2023-09-30 | $2,616 |
| 2023-06-30 | $2,648 |
| 2023-03-31 | $2,567 |
| 2022-12-31 | $2,464 |
| 2022-09-30 | $2,431 |
| 2022-06-30 | $2,419 |
| 2022-03-31 | $2,359 |
| 2021-12-31 | $2,263 |
| 2021-09-30 | $2,128 |
| 2021-06-30 | $2,114 |
| 2021-03-31 | $2,066 |
| 2020-12-31 | $2,009 |
| 2020-09-30 | $1,540 |
| 2020-06-30 | $1,499 |
| 2020-03-31 | $1,428 |
| 2019-12-31 | $1,671 |
| 2019-09-30 | $1,287 |
| 2019-06-30 | $1,223 |
| 2019-03-31 | $1,171 |
| 2018-12-31 | $801 |
| 2018-09-30 | $891 |
| 2018-06-30 | $853 |
| 2018-03-31 | $816 |
| 2017-12-31 | $1,301 |
| 2017-09-30 | $1,427 |
| 2017-06-30 | $1,203 |
| 2017-03-31 | $1,134 |
| 2016-12-31 | $1,141 |
| 2016-09-30 | $1,233 |
| 2016-06-30 | $1,150 |
| 2016-03-31 | $1,174 |
| 2015-12-31 | $1,151 |
| 2015-09-30 | $735 |
| 2015-06-30 | $731 |
| 2015-03-31 | $725 |
| 2014-12-31 | $1,293 |
| 2014-09-30 | $720 |
| 2014-06-30 | $530 |
| 2014-03-31 | $514 |
| 2013-12-31 | $494 |
| 2013-09-30 | $518 |
| 2013-06-30 | $554 |
| 2013-03-31 | $554 |
| 2012-12-31 | $544 |
| 2012-09-30 | $169 |
| 2012-06-30 | $158 |
| 2012-03-31 | $161 |
| 2011-12-31 | $537 |
| 2011-09-30 | $161 |
| 2011-06-30 | $162 |
| 2011-03-31 | $160 |
| 2010-12-31 | $151 |
| 2010-09-30 | $144 |
| 2010-06-30 | $136 |
| 2010-03-31 | $136 |
| 2009-12-31 | $137 |
| 2009-09-30 | $296 |
| 2009-06-30 | $300 |
| 2009-03-31 | $237 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $144.721B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.851B | 27.88 |
| Boston Scientific (BSX) | United States | $151.436B | 37.91 |
| EssilorLuxottica (ESLOY) | France | $129.653B | 0.00 |
| Medtronic (MDT) | Ireland | $110.247B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.183B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.320B | 28.03 |
| Agilent Technologies (A) | United States | $32.988B | 21.51 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Terumo (TRUMY) | Japan | $26.976B | 35.04 |
| Koninklijke Philips (PHG) | Netherlands | $21.839B | 15.32 |
| Insulet (PODD) | United States | $21.652B | 84.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.103B | 11.63 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.776B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.410B | 22.31 |
| Lantheus Holdings (LNTH) | United States | $5.591B | 14.10 |
| Prestige Consumer Healthcare (PBH) | United States | $4.170B | 18.63 |
| Perrigo (PRGO) | Ireland | $3.636B | 9.22 |
| Haemonetics (HAE) | United States | $3.462B | 15.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.203B | 26.62 |
| ICU Medical (ICUI) | United States | $3.152B | 23.24 |
| GN Store Nord (GNNDY) | Denmark | $2.272B | 18.82 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.11 |
| QuidelOrtho (QDEL) | United States | $1.870B | 12.86 |
| AtriCure (ATRC) | United States | $1.579B | 0.00 |
| Acuren (TIC) | United States | $1.283B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.120B | 11.37 |
| Neogen (NEOG) | United States | $1.035B | 13.25 |
| Green Thumb Industries (GTBIF) | United States | $1.018B | 22.91 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.991B | 12.67 |
| InMode (INMD) | Israel | $0.853B | 8.59 |
| Kestra Medical Technologies (KMTS) | United States | $0.822B | 0.00 |
| CeriBell (CBLL) | United States | $0.668B | 0.00 |
| Evolus (EOLS) | United States | $0.605B | 0.00 |
| Owens & Minor (OMI) | United States | $0.562B | 4.67 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.537B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.514B | 0.00 |
| Valneva SE (VALN) | France | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.363B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.351B | 0.00 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.86 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.287B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Quanterix (QTRX) | United States | $0.245B | 0.00 |
| ZimVie (ZIMV) | United States | $0.241B | 10.95 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.222B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.17 |
| Biote (BTMD) | United States | $0.219B | 6.17 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.45 |
| TriSalus Life Sciences (TLSI) | United States | $0.200B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.52 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.02 |
| Jin Medical (ZJYL) | China | $0.101B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.29 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.079B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 61.29 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.03 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |